Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK on course for COVID-19 vaccination target as shots reach 200,000 a day - Hancock

Sun, 10th Jan 2021 10:35

* UK targets 14 million shots by mid-Feb, every adult by
autumn

* New variant causing a surge in cases

* Health Secretary will not speculate on even tougher
restrictions
(Adds further details on tests, further lockdown measures)

By Paul Sandle

LONDON, Jan 10 (Reuters) - Britain is on course to have
immunised its most vulnerable people against COVID-19 by
mid-February and offering a shot to every adult by autumn, with
some 2 million people having already received a first dose, its
health secretary said on Sunday.

"Over the last week we've vaccinated more people than in the
entirety of December, so we're accelerating the roll-out," Matt
Hancock told BBC TV.

Britain is battling surging infections but is pinning its
hopes on rapid immunisation to enable life to start returning to
some degree of normality by the spring.

Hancock said around 2 million people had already received a
first shot of the Pfizer-BioNTech or the Oxford-AstraZeneca
vaccine.

"We've now vaccinated around a third of all of the over 80s,
so (we are making) very, very good progress," he said.

For the government to meet its goal of vaccinating more than
14 million people by mid-February, comprising the over-70s, the
clinically vulnerable - the elderly or with pre-existing
conditions - and health and social-care workers, it needs to
deliver 2 million shots a week.

The current rate is around 200,000 a day, Hancock said.

Seven mass vaccination centres will open this week,
supplementing almost 1,000 doctors surgeries and hospitals
offering shots. Hancock said every adult would be offered a
vaccine by the autumn.

Queen Elizabeth and her husband Philip, both in their
nineties, have received vaccinations, Buckingham Palace said on
Saturday.

SURGING CASES
A highly transmissible new variant of the virus is surging
around Britain and Prime Minister Boris Johnson has imposed a
third national lockdown in England to try to stem the pandemic
before the most vulnerable are immunised. Wales, Scotland and
Northern Ireland have imposed similar measures.

More than 80,000 people in Britain have died within 28 days
of receiving a positive COVID-19 test, the fifth highest
official death toll globally, and over 3 million people have
tested positive.

England's Chief Medical Officer Chris Whitty said on Sunday
the national health service in parts of the country was facing
"the most difficult situation anyone could remember".

Hancock did not rule out a tougher lockdown, saying he would
"not speculate" on further restrictions, although he added that
the "vast majority" of people were complying with current rules.
(
Editing by Mark Heinrich and Frances Kerry)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.